Showing posts with label Headache Research. Show all posts
Showing posts with label Headache Research. Show all posts

Daily Science Journal (Nov. 19, 2007) — People with migraines have differences in an area of the brain that helps process sensory information, including pain, according to a new study.

The study found that part of the cortex area of the brain is thicker in people with migraine than in people who do not have the neurological disorder.

Comparing 24 people with migraine to 12 people without migraine, the study found that the somatosensory cortex area of the brain was an average of 21 percent thicker in those with migraine.

"Repeated migraine attacks may lead to, or be the result of, these structural changes in the brain," said study author Nouchine Hadjikhani, MD, of The Martinos Center for Biomedical Imaging at Massachusetts General Hospital in Boston. "Most of these people had been suffering from migraines since childhood, so the long-term overstimulation of the sensory fields in the cortex could explain these changes. It's also possible that people who develop migraines are naturally more sensitive to stimulation."


Hadjikhani said the results indicate that the brain's sensory mechanisms are important components in migraine. "This may explain why people with migraines often also have other pain disorders such as back pain, jaw pain, and other sensory problems such as allodynia, where the skin becomes so sensitive that even a gentle breeze can be painful."

Other studies have shown changes in the cortex. The area becomes thinner in neurological disorders such as multiple sclerosis and Alzheimer's disease. But the area thickens with extensive motor training and learning.

This research is published in the November 20, 2007, issue of Neurology®, the medical journal of the American Academy of Neurology.

The study was supported by grants from the National Institutes of Health, the Swiss Heart Foundation, and the Harvard School of Dental Medicine Dean's Award.

Adapted from materials provided by American Academy of Neurology, via EurekAlert!, a service of AAAS.

------------------------------------------------------------------------

Add On Article :

Scientists Identify Protein That May Promote Migraines

A University of Iowa study may provide an explanation for why some people get migraine headaches while others do not. The researchers found that too much of a small protein called RAMP1 appears to "turn up the volume" of a nerve cell receptor's response to a neuropeptide thought to cause migraines.

The neuropeptide is called CGRP (calcitonin gene-related peptide) and studies have shown that it plays a key role in migraine headaches. In particular, CGRP levels are elevated in the blood during migraine, and drugs that either reduce the levels of CGRP or block its action significantly reduce the pain of migraine headaches. Also, if CGRP is injected into people who are susceptible to migraines, they get a severe headache or a full migraine.

"We have shown that this RAMP protein is a key regulator for the action of CGRP," said Andrew Russo, Ph.D., UI professor of molecular physiology and biophysics. "Our study suggests that people who get migraines may have higher levels of RAMP1 than people who don't get migraines."

RAMP1 is a normal, required subunit of the CGRP receptor. Russo and his colleagues found that overexpression of RAMP1 protein in nerve cells increased the sensitivity and responsiveness of CGRP receptors to the neuropeptide -- more RAMP1 made CGRP receptors react to much lower concentrations of CGRP than usual and caused the receptors to respond more vigorously to the neuropeptide.

The UI team also engineered mice to express human RAMP1 in their nervous system in addition to the normal mouse version of the protein. These mice had double the amount of inflammation in response to CGRP than did normal mice. Nerve-induced inflammation is one of the effects associated with migraine headache.

Russo explained that his study raises the possibility that people who have migraines may have subtle genetic differences in the RAMP1 gene that result in increased levels of RAMP1 protein.

"There is clearly a genetic difference between people who get migraines and those who do not, and we think that difference could be RAMP1. Our studies provide a reason to look for variations in the DNA that encodes RAMP1 in humans," he said.

The study also suggests that the mice engineered to produce elevated levels of RAMP1 protein may be a good model for studying migraine and specifically trying to understand how the neuropeptide, CGRP, is working.

The UI team investigated CGRP receptors in the trigeminal nerve, which is responsible for relaying almost all sensory perception, including pain and touch, for the front of the head. The UI findings reinforce the emerging view that CGRP receptors in the trigeminal nerve play a key role in migraine headache.

However, there are other CGRP receptors throughout the body, and elevated CGRP levels are implicated in other types of pain, including arthritis. Russo predicts that his group's findings about RAMP1 will have implications for pain research beyond migraine headaches.

The study was funded by the National Institutes of Health and published in the Journal of Neuroscience.

Adapted from materials provided by University of Iowa.



Read the rest of this entry »

Daily Science Journal (Sep. 12, 2007) — Migraines are more than a bad headache. As nearly 30 million Americans can attest, the throbbing pain of a migraine can be debilitating, lasting from a few hours to several days. The condition can be aggravated by light, sounds, odors, exercise, even routine physical activities. Nausea, with or without vomiting, may occur.

Nearly 30 million Americans suffer from migraines. (Credit: iStockphoto/Guillermo Perales Gonzalez)

Fortunately, treatment helps most people who have migraines.

Doctors may recommend preventive medications for patients who have two or more debilitating episodes a month. Typically the medication is taken at regular intervals, often daily. Antidepressants, anti-seizure medications and cardiovascular drugs may help prevent migraines.


Infrequently, nonprescription nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen (Advil, Motrin, others) or naproxen sodium (Aleve, others) may help. Injections of botulinum toxin type A (Botox) is an alternative for people who can’t take or don’t respond well to preventive medications. However, this use of Botox for migraine prevention is not approved by the Food and Drug Administration.

Pain relief drugs for migraines should be taken as soon as symptoms begin. Mild migraines may respond to NSAIDs or aspirin. A moderate migraine may respond to a nonprescription combination of a drug containing acetaminophen, aspirin and caffeine. Other drug categories used to treat pain include triptans, which mimic the action of the brain chemical serotonin; anti-nausea and related drugs; and ergots, which were used for decades before the more recent introduction of triptans.

Some patients find relief from alternative therapies. The National Institutes of Health has concluded that acupuncture may help control headaches. A study in the journal Headache showed that a combination of yoga, breathing exercises and relaxation techniques reduces migraine frequency and pain.

Some find benefit in herbal remedies, such as butterbur, which appears to be safe if taken for a short period to prevent migraines. In addition, the supplement coenzyme Q10 appears to reduce migraine frequency for some. Patients who consider alternative therapies should consult their physician about the pros and cons and to prevent any drug interactions.

The September issue of Mayo Clinic Health Letter provides more information on treatments to prevent migraines and stop the pain.

Adapted from materials provided by Mayo Clinic, via Newswise.



Read the rest of this entry »

Daily Science Journal (Jun. 19, 2007) — Five years ago, Sharon Schafer Bennett suffered from migraines so severe that the headaches disrupted her life, kept her from seeking a job and interfered with participation in her children's daily activities.

Plastic surgeon Dr. Jeffrey Janis marks a site that, using the anti-wrinkle drug Botox, pinpointed a muscle later removed to help relieve Sharon Schafer Bennett's severe migraines. (Credit: Image courtesy of UT Southwestern Medical Center)

Now, thanks to an innovative surgical technique performed by a UT Southwestern Medical Center plastic surgeon who helped pioneer the procedure, the frequency and intensity of Mrs. Bennett's migraines have diminished dramatically -- from two to three per week to an occasional one every few months.


The technique -- performed by a handful of plastic surgeons in the U.S. -- includes using the anti-wrinkle drug Botox to pinpoint which of several specific muscles in the forehead, back of the head or temple areas may be serving as "trigger points" to compress, irritate or entrap nerves that could be causing the migraine. Because Botox temporarily paralyzes muscles, usually for about three months, it can be used as a "litmus test" or "marker" to see if headaches go away or become less intense while the Botox's effects last, said Dr. Jeffrey Janis, assistant professor of plastic surgery.

If the Botox is successful in preventing migraines or lessening their severity, then surgery to remove the targeted muscle is likely to accomplish the same result, but on a more long-term and possibly permanent basis, he said.

For Mrs. Bennett, the surgery proved to be life-altering.

"I can't even begin to tell you what a change this has made in my life," said Mrs. Bennett, 45, a Houston-area resident. "For the first time in years, I can live like a normal human being and do all the normal 'mom' and 'wife' things that the migraines physically prevented me from doing. My family thinks it's great because they don't have to put their lives on hold numerous times a week because of my migraines. I'm also going back to school to get a second degree, something I could never have considered before."

Dr. Janis said: "Many neurologists are using Botox to treat migraines, but they are making the injections in a 'headband-like' circle around the forehead, temple and skull. They are not looking at finding the specific location of the headache's trigger point. While patients may get temporary relief, after the Botox wears off they will have to go back and get more injections or continue medications for migraines.

"It's like a math equation. I will inject the Botox into one trigger point at a time and leave the others alone. The Botox is used as a diagnostic test to determine what trigger point is causing the problem. If patients get a benefit from the Botox, they likely will get a benefit from the surgery. If there's no benefit from the Botox, then there won't be a benefit from the surgery."

Dr. Janis began collaborating more than five years ago with Dr. Bahman Guyuron, a plastic surgeon at Case Western Reserve University and the first to explore using surgery to relieve migraines, following the revelation by several of his patients that their migraines had disappeared after they had cosmetic brow lifts. Dr. Janis has assisted his colleague by performing anatomical studies on cadavers to explore the nerves and pathways that might cause migraines. Together they have identified four specific trigger points and developed a treatment algorithm that includes using Botox prior to deciding whether to perform surgery.

During the past several years, numerous peer-reviewed articles have been published in Plastic & Reconstructive Surgery detailing their research efforts and the researchers have presented the technique at professional meetings of plastic surgeons.

Approximately 28 million Americans, 75 percent of those women, suffer from migraines, according to the National Institutes of Health. For employers, that translates into an estimated 157 million lost workdays annually.

"A migraine is something you can't explain to someone who hasn't had one," said Mrs. Bennett, who began suffering monthly migraines as a teenager. As she grew older, the headaches become more frequent and unpredictable. "They were messing up my life. I couldn't make any commitments or plan activities for my kids. This surgery has made a huge difference in my life. It's awesome."

Dr. Janis only sees patients who have been diagnosed with recurring migraines by a neurologist and have tried other treatments that have failed.

"Plastic surgeons are not in the business of diagnosing and treating headaches," he said. "This is a novel method of treatment that is proving to be effective and potentially more long lasting than other things used before. But it is still in its infancy."

Adapted from materials provided by UT Southwestern Medical Center.



Read the rest of this entry »